Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
Public ClinicalTrials.gov record NCT01436500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Randomized, Controlled Study to Determine the Safety and Pharmacokinetics of Ifetroban Injection in Hepatorenal Syndrome
Study identification
- NCT ID
- NCT01436500
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cumberland Pharmaceuticals
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Ifetroban Injection Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2011
- Primary completion
- May 31, 2015
- Completion
- Jun 30, 2015
- Last update posted
- Feb 28, 2017
2011 – 2015
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Arizona | Phoenix | Arizona | 85054 | — |
| UCSD, Hillcrest Medical Center Hospital | La Jolla | California | 92093 | — |
| UCSF (University of California-San Francisco) | San Francisco | California | 94143 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Indiana University (Division of Gastroenterology/Hepatology) | Indianapolis | Indiana | 46202 | — |
| University of Michigan Hospital | Ann Arbor | Michigan | 48109 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Baylor All Saints Medical Center | Fort Worth | Texas | 76104 | — |
| University of Utah Health Sciences Center | Salt Lake City | Utah | 84132 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01436500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01436500 live on ClinicalTrials.gov.